{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:21:41Z","timestamp":1780046501051,"version":"3.53.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-033599"],"award-info":[{"award-number":["INV-033599"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bangladesh is entering from low-income to lower-middle-income status in 2020, and this will be completed in the next 5 years. With gross national income growing, vaccines will need to be procured through private market for the Expanded Program on Immunization. A cost-benefit analysis is needed to evaluate vaccine demand in different socioeconomic groups in the country, to inform this procurement. Moreover, disease burden studies and awareness of importance of specific vaccines are needed as we move forward. A life-course approach to vaccination may enable whole society to realize the full potential of vaccination and address most significant threats to its success over time.<\/jats:p>","DOI":"10.1093\/infdis\/jiab455","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T19:13:00Z","timestamp":1631560380000},"page":"S749-S753","source":"Crossref","is-referenced-by-count":7,"title":["Life-Course Approach to Vaccination in Bangladesh for Meeting the Health and Health-Related Sustainable Development Goals: A Commentary"],"prefix":"10.1093","volume":"224","author":[{"given":"Taufiqur Rahman","family":"Bhuiyan","sequence":"first","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiqul","family":"Islam","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh"},{"name":"School of Medical Science, Griffith University, Gold Coast, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"2021122015220005500_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3329\/bioethics.v9i3.48912","article-title":"Mass vaccination programme: public health success and ethical issues\u2014Bangladesh perspective","volume":"9","author":"Nurunnabi","year":"2018","journal-title":"Bangladesh J Bioeth"},{"key":"2021122015220005500_CIT0002","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jama.2018.0708","article-title":"Association between estimated cumulative vaccine antigen exposure through the first 23 months of life and non-vaccine-targeted infections from 24 through 47 months of age","volume":"319","author":"Glanz","year":"2018","journal-title":"JAMA"},{"key":"2021122015220005500_CIT0003","doi-asserted-by":"crossref","first-page":"e20173310","DOI":"10.1542\/peds.2017-3310","article-title":"Infant hospitalizations and mortality after maternal vaccination","volume":"141","author":"Sukumaran","year":"2018","journal-title":"Pediatrics"},{"key":"2021122015220005500_CIT0004","volume-title":"Bangladesh introduces new vaccine to prevent severe forms of child pneumonia and meningitis","author":"Gavi, the Vaccine Alliance","year":"2009"},{"key":"2021122015220005500_CIT0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-777X.77298","article-title":"Combination vaccines","volume":"3","author":"Skibinski","year":"2011","journal-title":"J Glob Infect Dis"},{"key":"2021122015220005500_CIT0006","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2019.09.016","article-title":"The life-course approach to vaccination: harnessing the benefits of vaccination throughout life","volume":"37","author":"Tate","year":"2019","journal-title":"Vaccine"},{"key":"2021122015220005500_CIT0007","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14760584.2017.1371595","article-title":"Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa","volume":"16","author":"Shah","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2021122015220005500_CIT0008","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMp2034517","article-title":"Emerging infectious diseases\u2014learning from the past and looking to the future","volume":"384","author":"Elias","year":"2021","journal-title":"N Engl J Med"},{"key":"2021122015220005500_CIT0009","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122015220005500_CIT0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/01.inf.0000101851.57263.63","article-title":"Appropriate antibiotic use and why it is important: the challenges of bacterial resistance","volume":"22","author":"Lieberman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"2021122015220005500_CIT0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C","article-title":"Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules","volume":"9","author":"Miller","year":"2000","journal-title":"Health Econ"},{"key":"2021122015220005500_CIT0012","author":"Organization for Economic Co-operation and Development"},{"key":"2021122015220005500_CIT0013","volume-title":"World population prospects 2019: highlights.","author":"United Nations Department of Economic and Social Affairs, Population Division","year":"2019"},{"key":"2021122015220005500_CIT0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/21645515.2017.1356962","article-title":"Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh","volume":"14","author":"Sarker","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2021122015220005500_CIT0015","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","article-title":"Global cholera epidemiology: opportunities to reduce the burden of cholera by 2030","volume":"218","author":"Legros","year":"2018","journal-title":"J Infect Dis"},{"key":"2021122015220005500_CIT0016","volume-title":"Ending cholera: a global roadmap to 2030 strategy","author":"World Health Organization","year":"2017"},{"key":"2021122015220005500_CIT0017","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2021122015220005500_CIT0018","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(18)30993-0","article-title":"Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh","volume":"391","author":"Qadri","year":"2018","journal-title":"Lancet"},{"key":"2021122015220005500_CIT0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/tropicalmed6010032","article-title":"Licensed and recommended inactivated oral cholera vaccines: from development to innovative deployment","volume":"6","author":"Deen","year":"2021","journal-title":"Trop Med Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab455\/40426778\/jiab455.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S749\/41826264\/jiab455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S749\/41826264\/jiab455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T15:26:09Z","timestamp":1640013969000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_7\/S749\/6373867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":19,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2021,9,22]]},"published-print":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab455","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,15]]},"published":{"date-parts":[[2021,9,22]]}}}